Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of North Carolina, Chapel Hill
Assistance Publique - Hôpitaux de Paris
Brain Inflammation Collaborative
Massachusetts General Hospital
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire, Amiens